Monthly Archives: September 2015
Defining value in the MBS Review
In May 2015 the Federal Government announced a review of the Medicare Benefits Schedule (MBS) with a view to bringing the MBS up-to-date and increase the value derived from the more than 5,700 listed items. The announcement of this review … Continue reading
Commercial Eyes joins Medicines New Zealand
While Commercial Eyes has been providing a full range of services to our clients across the Tasman for a number of years we have now highlighted our commitment to New Zealand by recently joining Medicines New Zealand. Two of our … Continue reading
commercial eyes recruiting: senior medical affairs consultant
Our Medical Services team is looking for a Medical Affairs professional with at least 5 years’ experience in a Medical Affairs role and with 2 years’ experience in project management. This is a full or part-time position, based in our … Continue reading
Clinical Trials – A Patient Centred Focus
Patients today aren’t just taking part in clinical trials – they are playing an increasing role in the design and development of clinical trials. This is an important step forward in the clinical trial process. Patient input helps companies better … Continue reading
Will the Review of Medicines and Medical Devices deliver on streamlining the regulatory process?
The first in a series of progress reports The Review of Medicines and Medical Devices Regulation (RMMDR), which was undertaken by an independent panel of eminent opinion leaders with considerable experience in the National Medicines Policy framework, was commissioned by … Continue reading
Commercial Eyes Recruiting: Medical Information Associate/Consultant
Our Medical Information group is looking for Medical Information professionals with at least 1-3 years experience in a Drug/Medical Information role in a pharmaceutical company or hospital setting. There are two vacancies available: one permanent full time and one on … Continue reading
PHARMAC: The more things change…
Following an internal review and extensive community consultation process, New Zealand’s Pharmaceutical Management Agency (PHARMAC) is changing the way it makes decisions about the funding of medicines and medical devices. The overarching objective of PHARMAC will remain “to secure for … Continue reading
Dr Greg Pearce – Australia must agree on biosimilar approach
Our new Director, Regulatory Services, Dr Greg Pearce, has written an article for Pharma in Focus on the challenges biosimilars pose for the Australian medicines industry. The article looks at the uncertainties that are yet to be resolved, as well … Continue reading
Dr Greg Pearce – new Director, Regulatory Services
Commercial Eyes is delighted to announce that as of today, Dr Greg Pearce is our new Director, Regulatory Services. Greg has been with Commercial Eyes since 2013 as a Senior Regulatory Consultant and is a welcome addition to our leadership … Continue reading
